UVA found that fluvoxamine may prevent dangerous immune system overreactions, a major threat to COVID-19 patients.
- About
- Offices
- Initiatives
- Resources
- Give
COVID-19: UVA Discovery Spurs Clinical Trial of Antidepressant to Fight Virus
Office of the Vice President for Research
Varsity Hall
Box 400301
136 Hospital Drive
Charlottesville, VA 22904
PHONE: 434.924.3606
EMAIL: AskResearch@virginia.edu